CinCor Pharma’s $193.6 Million IPO

Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

HashiCorp’s Initial Public Offering

Wilson Sonsini Goodrich & Rosati advised HashiCorp on the deal. Latham & Watkins represented the underwriters. HashiCorp®, a leader in multi-cloud infrastructure automation software, announced the pricing...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Backblaze’s IPO

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Backblaze on the deal. White & Case advised Oppenheimer & Co. Backblaze, a provider of cloud storage and...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here